Ponce, Kyrie Jay .
HRN: 26-46-17 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/30/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/30/2024
01/06/2025
INTRAVENOUS
592 Mg IV Drip
Every 6 Hours
PCAP-C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes